RUNX3 and neoplasm: In a platinum-sensitive OC cohort mostly comprised of patients with HGSC, the combination of CAMK2N1 (calcium/calmodulin dependent protein kinase II inhibitor 1) and RUNX3 (RUNX family transcription factor 3) methylation in tumor specimens was associated with shorter OS and PFS [57].